Query Form

Paracetamol (PARACIP)

  • 75mg/ml , Injectible
  • Manufacture: CIPLA
  • Rating: Rating Stars

    5.0

Injectible
  • 7.10
  • Qty:
  • Drug InStock IN STOCK

Substitutes

Add Another Drug
Brand NamePricePackSave (₹)Manufacturer
Injectible Inj, ULTRAGIN

Comp: (Paracetamol 250mg/ml )

3.55 1 -3.55 WYETH LTD
Injectible Inj, PANACT

Comp: (Paracetamol 500 mg)

5.80 1 -1.30 DWD
Injectible Inj, PARACIP

Comp: (Paracetamol 150 mg/ml )

6.00 1 -1.10 CIPLA
Injectible Inj, FEVASTIN

Comp: (Paracetamol 150 mg/ml )

7.02 1 -.08 TABLETS (INDIA) LTD

Know More On Paracetamol

Description

Paracetamol is a valuable central analgesic. It acts on CNS to produce analgesic and anti pyretic effects. It has negligible anti inflammatory action in therapeutic dose. It does not stimulate respiration, after acid base balance, causes less gastric irritation, have no effect on cellular metabolism or clotting factors, it is not uricosuric.

Indications

  • Fever
  • Pain

Side Effects

  • Epigastric Distress
  • Leucopenia is Rare
  • Nausea
  • Rash

Precautions

  • Hepatic Impairment
  • Renal Impairment

Contraindications

  • Analgesic Nephropathy

Interactions

Interact TypeSeverity
Increases Abosorption Domperidone
Increases hepatotoxicity Ethanol
Increases Abosorption Metoclopramide
Decreases effect Zidovudine

Consumption Details

Route/FormDoseAgeDays
Oral/ Tablets 0.5-1 gm Any Adult Physician Advice
Oral/ Tablets 15 mg/kg/dose Any Child Physician Advice
Oral/ Tablets 60 mg/kg/24hours Any Child Physician Advice
Oral/ Tablets 0.5-1 gm Any Adult Physician Advice
Oral/ Tablets 15 mg/kg/dose Any Child Physician Advice
Oral/ Tablets 60 mg/kg/24hours Any Child Physician Advice

Safety in pregnancy

Paracetamol (PARACIP) falls in Category B

Pregnancy CategoryDescription
Category B Either Animal-Reproduction studies have not demonstrated a foetal risk, but there are no controlled studies in pregnant women or animal-reproduction studies have shown an adverse effect (other than a decrease in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is no evidence of a risk in later trimesters).
Category C Either studies in animals have revealed adverse effects on the foetus (Teratogenic or Embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus.

Brand names

Brand names

Copyright 2017 Active Health Technologies LLP. ALL Rights Reserved.